Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 167

The DOI matches its Crossref record.

Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma

Open access
Komatsu, Shohei, Fukumoto, Takumi, Demizu, Yusuke, Miyawaki, Daisuke, Terashima, Kazuki, Sasaki, Ryohei, Hori, Yuichi, Hishikawa, Yoshio, Ku, Yonson, Murakami, Masao · 2011 · Cancer

Abstract

BACKGROUND: The objective of this study was to evaluate the clinical outcome of proton and carbon ion therapy for hepatocellular carcinoma (HCC). METHODS: In total, 343 consecutive patients with 386 tumors, including 242 patients (with 278 tumors) who received proton therapy and 101 patients (with 108 tumors) who received carbon ion therapy, were treated on 8 different protocols of proton therapy (52.8‐84.0 gray equivalents [GyE] in 4‐38 fractions) and on 4 different protocols of carbon ion therapy (52.8‐76.0 GyE in 4‐20 fractions). RESULTS: The 5‐year local control and overall survival rates for all patients were 90.8% and 38.2%, respectively. Regarding proton and carbon ion therapy, the 5‐year local control rates were 90.2% and 93%, respectively, and the 5‐year overall survival rates were 38% and 36.3%, respectively. These rates did not differ significantly between the 2 therapies. Univariate analysis identified tumor size as an independent risk factor for local recurrence in proton therapy, carbon ion therapy, and in all patients. Multivariate analysis identified tumor size as the only independent risk factor for local recurrence in proton therapy and in all patients. Child‐Pugh classification was the only independent risk factor for overall survival in proton therapy, in carbon ion therapy, and in all patients according to both univariate and multivariate analyses. No patients died of treatment‐related toxicities. CONCLUSIONS: Proton and carbon ion therapies for HCC were comparable in terms of local control and overall survival rates. These therapies may represent innovative alternatives to conventional local therapies for HCC. Cancer 2011;. © 2011 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.26134

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 167

Metadata

Authors
Komatsu, S., Fukumoto, T., Demizu, Y., Miyawaki, D., Terashima, K., Sasaki, R., Hori, Y., Hishikawa, Y., Ku, Y., & Murakami, M.
Venue
Cancer
Publisher
Wiley
Published
2011-04-14
Volume
117
Issue
21
Pages
4890-4904
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W1583490427
Cited by
167
References
0
FWCI
6.43
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma. https://app.cochat.ai/papers/10.1002/cncr.26134
The paper
Komatsu, S., Fukumoto, T., Demizu, Y., Miyawaki, D., Terashima, K., Sasaki, R., Hori, Y., Hishikawa, Y., Ku, Y., & Murakami, M. (2011). Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma. Cancer. https://doi.org/10.1002/cncr.26134

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.